START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients

Jeanine R.Jarnes Utz, Cindy Pham Lorentz, Dorothy Markowitz, Kyle D. Rudser, Brenda Diethelm-Okita, David Erickson, Chester B. Whitley

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds